Lymphoma-associated hemophagocytic lymphohistiocytosis: Experience in adults from a single institution

Annals of Hematology

Volumn 92, Issue 11, 2013, Pages 1529-1536

  Yu, Jui Ting ^a   Wang, Chen Yu ^a   Yang, Youngsen ^a   Wang, Ren Ching ^a   Chang, Kuang Hsi ^a   Hwang, Wen Li ^a   Teng, Chieh Lin Jerry ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TUNGHAI UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hematopoietic stem cell transplantation; Hemophagocytic lymphohistiocytosis; Lymphoma; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FERRITIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FERRITIN BLOOD LEVEL; HEMOPHAGOCYTIC SYNDROME; HUMAN; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; T CELL LYMPHOMA;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885636323     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1784-3     Document Type: Article

References (24)

1. Larroche C, Mouthon L (2004) Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 3(2):69-75. doi: 10.1016/S1568-9972(03)00091-0
2. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124-131. doi: 10.1002/pbc.21039
3. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S, Tawa A (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89(11):4100-4103
4. Behrens EM, Canna SW, Slade K, Rao S, Kreiger PA, Paessler M, Kambayashi T, Koretzky GA (2011) Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 121(6):2264-2277. doi: 10.1172/JCI43157
5. Henter JI, Arico M, Elinder G, Imashuku S, Janka G (1998) Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin N Am 12(2):417-433
6. Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, Kawabata Y, Yanagiya N, Ichikawa Y, Miura AB, Miura I (2001) A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 74(2):209-213
7. Han AR, Lee HR, Park BB, Hwang IG, Park S, Lee SC, Kim K, Lim HY, Ko YH, Kim SH, Kim WS (2007) Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol 86(7):493-498. doi: 10.1007/s00277-007-0278-6
8. Yu JT, Hwang WL, Wang RC, Teng CL (2012) Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis. Ann Hematol 91(5):805-807. doi: 10.1007/s00277-011-1328-7
9. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117(19):5019-5032. doi: 10.1182/blood-2011-01- 293050
10. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649-655
11. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579-586. doi: 10.1200/JCO.2006.09.2403
12. Hosing C, Champlin RE (2011) Stem-cell transplantation in T-cell non-Hodgkin's lymphomas. Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO 22(7):1471-1477. doi: 10.1093/annonc/mdr140
13. Bhagwati NS, Oiseth SJ, Abebe LS, Wiernik PH (2004) Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entity. Ann Hematol 83(4):247-250. doi: 10.1007/s00277-003-0757-3
14. Pfreundschuh M, Kuhnt E, Trumper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, Lopez-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N (2011) CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 12(11):1013-1022. doi: 10.1016/S1470-2045(11)70235-2
15. Evstatiev R, Gasche C (2012) Iron sensing and signalling. Gut 61(6):933-952. doi: 10.1136/gut.2010.214312
16. Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ, Santambrogio P, Arosio P, Ramm GA (2009) Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49(3):887-900. doi: 10.1002/hep.22716
17. Tong H, Ren Y, Liu H, Xiao F, Mai W, Meng H, Qian W, Huang J, Mao L, Tong Y, Wang L, Qian J, Jin J (2008) Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome. Leuk Lymphoma 49(1):81-87. doi: 10.1080/10428190701713630
18. Machaczka M, Nahi H, Karbach H, Klimkowska M, Hagglund H (2012) Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation. Med Oncol 29(2):1231-1236. doi: 10.1007/s12032-011- 9963-3
19. Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M, Narni F, Patriarca F, Boccadoro M, Benedetti F, Rambaldi A, Gianni AM, Tarella C (2004) Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 22(11):2172-2176. doi: 10.1200/JCO.2004.12.050
20. Shimazaki C, Inaba T, Nakagawa M (2000) B-cell lymphoma-associated hemophagocytic syndrome. Leuk Lymphoma 38(1-2):121-130. doi: 10.3109/10428190009060325
21. Reddy N, Oluwole O, Greer JP, Goodman S, Engelhardt B, Jagasia MH, Savani BN (2012) Superior long-term outcome of patients with early transformation of non-hodgkin lymphoma undergoing stem cell transplantation. Clin Lymphoma Myeloma Leuk 12(6):406-411. doi: 10.1016/j.clml.2012.07.003
22. Tsuchiyama J, Imajo K, Yoshino T, Nanba N, Toyota A, Yoshida C, Fujii K, Kondo E, Okazuka K, Hashimoto S, Toba K, Fuse I, Aizawa Y, Harada M, Tsubota T (2002) High-dose chemotherapy and autologous peripheral blood stem cell transplantation for treatment of unspecified peripheral T-cell lymphoma presented with hepatosplenomegaly and hypercytokinemia syndrome: report of three cases. Ann Hematol 81(10):588-592. doi: 10.1007/s00277-002-0526-8
23. Foss F (2003) Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches. Leuk Lymphoma 44(Suppl 3):S55-S61
24. Jain S, Zain J, O'Connor O (2012) Novel therapeutic agents for cutaneous T-cell lymphoma. J Hematol Oncol 5:24. doi: 10.1186/1756-8722-5-24